QUICKLINKS AND VIEW OPITONS
Acomplia (rimonabant): Forty percent of patients lose at least 10% of their body weight
Friday, March 11, 2005 2:36 pm Email this article
At least forty percent of subjects who have been given 20 mg of Acomplia (rimonabant) per day in addition to a reduced calorie diet have lost more than 10 percent of their body weight. 70% of subjects lost at least 5% of their body weight
More than seventy percent of patients given 20 mg of Acomplia (rimonabant) per day in addition to a diet lost at least 5 percent of their body weight.
Waist reduced 3.6 inches
Patients with metabolic syndrome (insulin resistance, etc) reduced their waist by an average of 3.6 inches (9.1 cm).
HDL increased 23%
Subjects given Acomplia (rimonabant) have had an average increase in HDL cholesterol levels of 23 percent.
Acomplia not approved for sale in the U.S. as of March 11, 2004
Acomplia (rimonabant) has not been approved for sale in the U.S. as of March 11, 2004.
Boyd S, Fremming B. Rimonabant-a selective cb1 antagonist (april). Ann Pharmacother. 2005 Mar 8.
School of Pharmacy and Health Professionals
Omaha, NE, USA
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.